UBS Maintains Buy on Colgate-Palmolive, Raises Price Target to $100
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $98 to $100.
UBS analyst Peter Grom maintains Colgate-Palmolive (NYSE:CL) with a Buy and raises the price target from $98 to $100.